Literature DB >> 34178822

Beneficial effect of Zingiber officinale on olanzapine-induced weight gain and metabolic changes.

Mrityunjaya B Ullagaddi1, B M Patil1, Pukar Khanal1.   

Abstract

AIM: The present study aimed to investigate the effect of Zingiber officinale (ZO) extract on weight gain, food intake, locomotor activity, and lipid and glucose metabolism in olanzapine-treated rats.
METHODS: The hydroalcoholic extract of ZO was prepared by macerating the coarse dry powder in 70% v/v ethanol for 7 days, filtered, and concentrated under reduced pressure. Animals were divided into six groups containing six animals in each. Three doses of extract (100, 200, and 400 mg/kg, p.o.) were co-administered with olanzapine 2 mg/kg i.p for 21 days. Bodyweight and food intake were recorded at the interval of three days and locomotor activity once a week. At the end of the study oral glucose tolerance test was performed followed by the estimation of lipid profile.
RESULTS: Co-administration of hydroalcoholic extract of ZO with olanzapine ameliorated olanzapine-induced weight gain and hyperphagia. Similarly, ZO extract also improved pancreatic β-cell function and glucose and lipid metabolism.
CONCLUSIONS: ZO extract ameliorated olanzapine-induced weight gain and hyperphagia by improving pancreatic β-cell functions and lipid metabolism. © Springer Nature Switzerland AG 2021.

Entities:  

Keywords:  Lipid metabolism; Locomotor activity; Olanzapine; Weight gain; Zingiber officinale

Year:  2021        PMID: 34178822      PMCID: PMC8212323          DOI: 10.1007/s40200-020-00695-x

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  26 in total

1.  Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.

Authors:  Pukar Khanal; Basanagouda M Patil
Journal:  J Integr Med       Date:  2020-10-07

2.  Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.

Authors:  SuJean Choi; Briana DiSilvio; JayLynn Unangst; John D Fernstrom
Journal:  Life Sci       Date:  2007-08-17       Impact factor: 5.037

3.  Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial.

Authors:  Grigori Joffe; Pirjo Takala; Evgueni Tchoukhine; Helinä Hakko; Mirjam Raidma; Hanna Putkonen; Markku Eronen; Pirkko Räsänen
Journal:  J Clin Psychiatry       Date:  2008-05       Impact factor: 4.384

4.  Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.

Authors:  Shona L Kirk; John Glazebrook; Ben Grayson; Joanna C Neill; Gavin P Reynolds
Journal:  Psychopharmacology (Berl)       Date:  2009-08-18       Impact factor: 4.530

5.  Inhibitory effect 6-gingerol on adipogenesis through activation of the Wnt/β-catenin signaling pathway in 3T3-L1 adipocytes.

Authors:  Chunbo Li; Lin Zhou
Journal:  Toxicol In Vitro       Date:  2015-10-21       Impact factor: 3.500

6.  Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway.

Authors:  Xue-Mei Liu; Xiao-Min Zhao; Chao Deng; Yan-Ping Zeng; Chang-Hua Hu
Journal:  Acta Pharmacol Sin       Date:  2019-02-06       Impact factor: 6.150

Review 7.  The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities.

Authors:  Derek M Erion; Hyun-Jun Park; Hui-Young Lee
Journal:  BMB Rep       Date:  2016-03       Impact factor: 4.778

8.  [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice.

Authors:  Mehdi Bin Samad; Md Nurul Absar Bin Mohsin; Bodiul Alam Razu; Mohammad Tashnim Hossain; Sinayat Mahzabeen; Naziat Unnoor; Ishrat Aklima Muna; Farjana Akhter; Ashraf Ul Kabir; J M A Hannan
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

Review 9.  Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.

Authors:  Madhubhashinee Dayabandara; Raveen Hanwella; Suhashini Ratnatunga; Sudarshi Seneviratne; Chathurie Suraweera; Varuni A de Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-22       Impact factor: 2.570

Review 10.  Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.

Authors:  John R Petrie; Tomasz J Guzik; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2017-12-11       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.